CO6290756A2 - Proceso para la preparacion de 6-sustituido -1-(2h)-isoquinolinonas - Google Patents

Proceso para la preparacion de 6-sustituido -1-(2h)-isoquinolinonas

Info

Publication number
CO6290756A2
CO6290756A2 CO10074960A CO10074960A CO6290756A2 CO 6290756 A2 CO6290756 A2 CO 6290756A2 CO 10074960 A CO10074960 A CO 10074960A CO 10074960 A CO10074960 A CO 10074960A CO 6290756 A2 CO6290756 A2 CO 6290756A2
Authority
CO
Colombia
Prior art keywords
compound
formula
protecting group
give
group
Prior art date
Application number
CO10074960A
Other languages
English (en)
Inventor
Kai Rossen
Hermut Wehlan
Plettenburg Oliver
Volker Kraft
Guenter Billen
Simon Gessler
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of CO6290756A2 publication Critical patent/CO6290756A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

1.- Un proceso para la preparación de un compuesto de fórmula (I)o una sal del mismo, donden es 1,2,3 ó4; y R1 es H o un grupo protector, que comprende las etapas de(A) hacer reaccionar un compuesto de fórmula (II)donde X es halógeno, en un disolvente adecuado y en presencia de una base seleccionada de un alcóxido de metal alcalino terciario, hidruro de metal alcalino o metal alcalino con un compuesto de fórmula (III)donde R1 es H o un grupo protector yn es 1, 2, 3 ó 4, para dar un compuesto de fórmula (lV)donde R1 es H o un grupo protector y n es 1, 2, 3 ó 4; y, si R1 es H, proteger el grupo aminopara dar un compuesto de fórmula (IV) en la que R1 es un grupo protector de amino; (B) hacer reaccionar un compuesto de fórmula (IV) con un compuesto de fórmula (V) R4-CH[N(R5)2]2 (V)donde R4 es -O-alquilo (C1-C6), y R5 es alquilo (C1-C6),para proporcionar un compuesto de fórmula (VI)donde R1 es un grupo protector y n es 1, 2, 3 ó 4; y(C) ciclar un compuesto de fórmula (VI) y opcionalmente eliminar el grupo protector en un disolvente adecuado y en presencia de un ácido hidrohálico para dar un compuesto de fórmula (I)en el que R1 es H o un grupo protector;(D) opcionalmente eliminar el grupo protector a partir de un compuesto de fórmula (I) obtenido en la etapa (C), en el que R1 es un grupo protector, para dar el compuesto de fórmula (I) en el que R1 es H, y(E) opcionalmente convertir un compuesto de fórmula (I) en su sal.
CO10074960A 2007-12-26 2010-06-22 Proceso para la preparacion de 6-sustituido -1-(2h)-isoquinolinonas CO6290756A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07291622 2007-12-26
US5655008P 2008-05-28 2008-05-28

Publications (1)

Publication Number Publication Date
CO6290756A2 true CO6290756A2 (es) 2011-06-20

Family

ID=39410019

Family Applications (1)

Application Number Title Priority Date Filing Date
CO10074960A CO6290756A2 (es) 2007-12-26 2010-06-22 Proceso para la preparacion de 6-sustituido -1-(2h)-isoquinolinonas

Country Status (19)

Country Link
US (1) US8716481B2 (es)
EP (1) EP2240441B1 (es)
JP (1) JP2011507921A (es)
KR (1) KR20100103646A (es)
CN (1) CN101910123A (es)
AR (1) AR071744A1 (es)
AU (1) AU2008340601A1 (es)
BR (1) BRPI0821837A2 (es)
CA (1) CA2710447A1 (es)
CL (1) CL2008003897A1 (es)
CO (1) CO6290756A2 (es)
HU (1) HUE025985T2 (es)
IL (1) IL206530A0 (es)
MA (1) MA31926B1 (es)
NZ (1) NZ586335A (es)
RU (1) RU2010131010A (es)
TW (1) TW200940525A (es)
UY (1) UY31577A1 (es)
WO (1) WO2009080335A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE028550T2 (en) 2011-07-08 2016-12-28 Sanofi Sa Polymorphs of 6- (Piperidin-4-yloxy) -2H-isoquinolin-1-one hydrochloride
KR101959711B1 (ko) 2011-07-08 2019-03-19 사노피 치환된 페닐 화합물
ES2568245T3 (es) 2011-07-08 2016-04-28 Sanofi Solvatos cristalinos de hidrocloruro de 6-(piperidin-4-iloxi)-2H-isoquinolin-1-ona
WO2013148512A1 (en) * 2012-03-26 2013-10-03 Dow Agrosciences Llc Materials and methods for the base-assisted synthesis of substituted heteroaromatics
EP3141235A1 (en) 2012-12-06 2017-03-15 IP Gesellschaft für Management mbH N-(6-((2r,3s)-3,4-dihydroxybutan-2-yloxy)-2-(4-fluorobenzylthio)pyrimidin-4-yl)-3-methylazetidine-l -sulfonamide
AR107354A1 (es) * 2016-01-13 2018-04-18 Bristol Myers Squibb Co Salicilamidas espiroheptanos y compuestos relacionados como inhibidores de rock
KR101700381B1 (ko) * 2016-06-27 2017-01-31 이에스콘트롤스(주) 와이파이를 이용한 무선 자동제어 장치 및 방법
WO2024030854A1 (en) 2022-08-01 2024-02-08 Valo Health, Inc. Process for preparing 6-substituted-1-(2h)-isoquinolinones and intermediate compound

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3732245A (en) * 1970-11-04 1973-05-08 Hoffmann La Roche Process and intermediates for the preparation of indoles from ortho-nitrotoluenes
BRPI0613861B8 (pt) * 2005-07-26 2021-05-25 Sanofi Aventis derivados de isoquinolona piperidinil-substituídos como inibidores de rho-cinase
TW200738682A (en) * 2005-12-08 2007-10-16 Organon Nv Isoquinoline derivatives

Also Published As

Publication number Publication date
AU2008340601A1 (en) 2009-07-02
EP2240441A1 (en) 2010-10-20
RU2010131010A (ru) 2012-02-10
HUE025985T2 (en) 2016-04-28
JP2011507921A (ja) 2011-03-10
CN101910123A (zh) 2010-12-08
UY31577A1 (es) 2009-08-03
BRPI0821837A2 (pt) 2015-06-16
AR071744A1 (es) 2010-07-14
IL206530A0 (en) 2010-12-30
CA2710447A1 (en) 2009-07-02
NZ586335A (en) 2011-08-26
KR20100103646A (ko) 2010-09-27
US20110021779A1 (en) 2011-01-27
CL2008003897A1 (es) 2009-05-22
US8716481B2 (en) 2014-05-06
MA31926B1 (fr) 2010-12-01
WO2009080335A1 (en) 2009-07-02
EP2240441B1 (en) 2015-06-03
TW200940525A (en) 2009-10-01

Similar Documents

Publication Publication Date Title
CO6290756A2 (es) Proceso para la preparacion de 6-sustituido -1-(2h)-isoquinolinonas
BR0211704A (pt) Processo para recuperar energia a partir de um gás
MX2010001905A (es) Sal de metal alcalino de acido glutamico acido n,n-diacetico, un proceso para preparar dicha sal, y el uso de la misma.
UA100367C2 (uk) Спосіб одержання мемантину і його гідрохлориду
DK2017258T3 (da) Fremgangsmåde til fremstilling af en radioaktiv fluormærket organisk forbindelse
UA102817C2 (ru) Способ синтеза агомелатина
MX2009005440A (es) Procedimiento para la produccion de derivados de fenilalanina que tienen estructuras de base de quinazolinodiona e intermediarios para la produccion.
IN2015DN02424A (es)
UA102220C2 (ru) Способ синтеза агомелатина
MX2014006992A (es) Disales de acido malonico y metodo para preparar dihaluros de malonilo.
IN2014DN05818A (es)
AR041360A1 (es) Proceso para la preparacion de valsartan
MY144180A (en) Method for producing strontium ranelate and its hydrates
TW201129535A (en) Alcoholic hydroxyl-containing compounds and making method
ME00455B (me) Novi postupak za industrijsku sintezu stroncijum ranelata i njegovih hidrata
GB201204023D0 (en) Process for producing V-Coelenterazine compounds
IL188716A0 (en) Method for preparing 4??-amino-4'-dimethyl-4-
AR038624A1 (es) Un procedimiento para preparar un derivado de fenilalanina e intermediarios del mismo
AR072776A1 (es) Procesos para la produccion de 2-amino-2-[2-(4-alquil c2-20-fenil)etil]propano-1,3-dioles y a compuestos intermediarios para usar con los mismos
WO2008093700A1 (ja) トレハロース化合物、その製造方法、及び該化合物を含有する免疫賦活剤
TW201129575A (en) Metal complex having pyridylphosphine compound, and method for producing alkyl methacrylate
ES2531054T3 (es) Condensación de fragmento de oligopéptido de cadena lateral protegida mediante el uso de subtilisinas en disolventes orgánicos
MY131849A (en) Process for preparing 5,6-diethyl-2,3-digydro-1h-inden-2-amine
HK1084937A1 (en) Process for reductive dehalogenation
IN2012DN00361A (es)

Legal Events

Date Code Title Description
FC Application refused